Indian Markets Outlook & Secorwise Stocks Outlook for the week – 18.Jul.2016 to 22.Jul.2016

Indian Markets Outlook for the week – 18.Jul.2016 to 22.Jul.2016
(Earnings, Parliament session key; RIL in focus) )

Apr-Jun earnings of key companies and the Monsoon Session of Parliament which starts Monday
would be key triggers for share indices next week, even as investors monitor the trend in global
markets. Underlying bias of equities remains positive, despite yesterday’s decline. However, sharp
gains in equities over the last month which took indices to their 11-month highs on Thursday are seen
capping the rise in share indices.

The Nifty 50 is seen testing the psychologically-important level of 8600 points next week, above
which it could rise towards the resistance of 8700 points, a technical based. Yesterday, the Nifty 50
closed at 8541.40 points, down 0.3%, while the S&P BSE Sensex ended down 0.4% at 27836.50.
Next week, Hindustan Unilever, UltraTech Cement, Wipro, HDFC Bank, ITC, Kotak Mahindra Bank,
and Axis Bank will be reporting their earnings for the June quarter. On Monday, the initial trigger for
the market would be Reliance Industries' robust quarterly earnings, following which investors would
shift focus to the Monsoon Session of Parliament.

Reliance Industries has yesterday reported a net profit of 75.5 bln rupees, sharply higher than estimate of 65.4 bln rupees. The company's gross refining margins in Apr-Jun came in at $11.5 per barrel. Investors would hope for the passage of the Constitutional Amendment Bill to introduce the Goods and Services Tax in the Monsoon Session of Parliament. According to reports, Finance Minister Arun Jaitley and Parliamentary Affairs Minister Ananth Kumar today met Leader of Opposition in Rajya Sabha, Ghulam Nabi Azad, to resolve issues surrounding the passage of the Bill to roll out the Goods and Services Tax with an aim to build consensus on the issue.

On Monday, shares of Monsanto India would also be in focus after thecompany, after market hours
today, said its parent company received a revised takeover bid from Germany's Bayer AG.